$ADMD What is a medical isotope? A medical isotope is a

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
$ADMD >

What is a medical isotope?
A medical isotope is a very small quantity of radioactive substance used in safe, cost-effective imaging and treatment of disease. New technologies enable medical isotopes to be delivered directly to the site of diseased cells. This is different from external beam radiation treatment where radiation is directed from outside of the body.
Who uses medical isotopes?
The medical specialty that utilizes medical isotopes for diagnosis and treatment is called nuclear medicine. The doctors that perform nuclear medicine procedures for cancer are called radiation oncologists.
What can medical isotopes do in diagnosis?
Radioisotopes give off energy that can be detected by special equipment. When small quantities are introduced into the body, the imaging equipment tracks their location and movement. This enables the doctors to learn more about the diseased tissues than a diagnostic procedure that just takes a picture from the outside. Medical isotope diagnostic procedures often facilitate an earlier and more complete disease diagnosis and therefore more rapid and effective treatment.
What can medical isotopes do in cancer treatment?
The energy given off by radioisotopes is very effective at zapping diseased cells. When they are delivered straight to the cancer cells, healthy tissues are spared while cancer cells are eliminated. Medical isotopes are delivered to the cancer cells in several different ways.
What different types of medical isotope treatments are there?
Brachytherapy is a form of cancer treatment where tiny "seeds" containing medical isotopes are accurately placed within and near a tumor. Brachytherapy is FDA approved and used for localized prostate cancer, liver cancer, head and neck cancers, gynecological cancers and others.

Radioimmunotherapy is a type of treatment where doctors inject antibodies that have isotopes attached like little backpacks. The antibodies (called monoclonal antibodies) then flow through the bloodstream and attach themselves to the cancerous cells. The energy from the medical isotopes is thus targeted straight to the cancer. This type of treatment is showing great promise for blood cancers such as leukemia, lymphoma, and multiple myeloma. Most Radioimmunotherapy treatments are still in clinical trials.

Medical isotopes can also be directed to cancerous cells by a carrier that has an attraction to a certain part of the body. Chemical phosphonates can be paired with medical isotopes and sent to the bone, since phosphonate is a natural building block of bone matrix. FDA approved treatments for pain associated with cancer that has spread to the bone are based on this delivery system. The medical isotope Iodine has been used for thyroid treatment for years because the isotope itself is naturally attracted to the thyroid.

Where are medical isotopes made?
Medical isotopes are made in either accelerators or nuclear reactors. Today, the United States imports about 90% of the medical isotopes used in hospitals and clinics. Our supply of medical isotopes is at risk to global conditions and the internal conditions of other countries.
Do we have sufficient supplies of medical isotopes to meet growing demands?
No. A few key isotopes with the potential to take cancer therapy to a new level of effectiveness are simply not available. The researchers who want to explore their potential are unable to do so. In addition, the success of treatments currently in clinical trials and awaiting FDA approval could usher in a serious supply problem once FDA approval is obtained. The end result could be patients unable to be treated with an effective therapy.

Demand for medical isotopes are projected to grow in the range of 8% to 20% per year for the next 20 years. Current U.S. production resources are not adequate to meet the increasing needs for use of the isotopes in research, diagnosis, and treatment.

Is there a potential U.S. source for medical isotopes?
Yes. The United States has a number of small active providers of a few isotopes suitable for medical use. Most sources are small commercial accelerators or university research nuclear reactors such as the Missouri University Research Reactor. Other possibilities are the creation or use of reactors and accelerators which can produce the quantities and types to fully support all needs.
Is our country going to utilize this source of medical isotopes?
We don't know. Unless there is a demonstrated need, resources will not be built. But, without the resources, many attractive short lived isotopes are not available to researchers.
Is there anything I can do to support medical isotope research and treatments?
Yes. Let your voice be heard. Tell your Congressmen, the Department of Energy, and the Department of Health and Human Services that you support all efforts at furthering medical isotope research. Write, call, or email to let them know you support production facilities as well as increased funding for research. Secondly, join Citizens for Medical Isotopes. Your support will help us reach more cancer patients and their families. It will further our efforts to help researchers develop better ways to fight cancer and other diseases.
What if somebody I know has cancer?
Contact our office. We can provide information that may help your friend or family member make an informed decision about treatment options or clinical trials opportunities. We don't give medical advice and are not qualified to do so. However, we can direct people and their doctors to resources about medical isotope treatments.
Are there any other diseases treatable with medical isotopes?
Yes. Medical isotopes are proving very helpful in treating cardiovascular disease. They effectively prevent re-clogging of arteries (restenosis) when used in conjunction with angioplasty (balloon therapy). Rheumatoid arthritis is commonly treated in Europe with injections of medical isotopes. At the basic research level, medical isotopes have been shown to kill HIV/AIDS
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HI-CHEW® Holiday Mix Debuts Three Seasonal Flavors

Updated Category News Views 82

HI-CHEW® Puts Holiday Cheer on the Shelves In the candy aisle, it’s never just about sugar—it’s about the flavor journey. This year, HI-CHEW® is pulling off a sweet, festive coup with its first-ever Holiday Mix, making sure that your taste buds aren't left out in the cold. But hey, I’m a seasoned investor talking about candy here, not stocks. Unwrapping the New...

Continue Reading
Maternal Role in Type 1 Diabetes: A Non-Genetic Angle

Updated Category News Views 6

Unveiling the Maternal Puzzle in Type 1 Diabetes So here's a stumper: how come kids of moms with type 1 diabetes dodge the disease more than kids of dads with it? Simple genes don't account for it, says a study from University of Colorado Anschutz. With nearly 7,000 kids in this research, you'd think they'd find a genetic smoking gun. Nope. It's pointing to something else...

Continue Reading
Sokolove Law Wins $28.8M Verdict for Misdiagnosis Case

Updated Category News Views 41

Jury Awards $28.8 Million in Misdiagnosis Case Well, here's a tale that's bound to ruffle some feathers in the medical community—$28.8 million tossed on the table because an emergency room missed a life-threatening aortic aneurysm. For the uninitiated, this isn't just chump change; it's the cost of dropping the ball when the stakes are as high as a human life. A jury in...

Continue Reading
O-I Glass Faces Legal Storm Over Misleading Investor Claims

Updated Category News Views 101

Turbulence Hits O-I Glass Stock Another day, another company in hot water—and today, it's O-I Glass, Inc. (NYSE: OI) we're talking about. The company's shares plummeted by 15.01% in one fell swoop on July 29, 2026, right after it dropped its financial bombshell. Let’s break this drama down, shall we? The Legal Brass Tacks Investors who took the bait on O-I Glass...

Continue Reading
New CEO Aims to Revolutionize Pregnancy Health Sector

Updated Category News Views 125

Revolution Brewing in Pregnancy Health Look, I’ve seen all sorts of execs take on new gigs, but when I hear about an industry veteran like David Stern stepping in as CEO at Mirvie, I sit up and take notice. It’s not just another leadership shuffle; it’s a potential game-changer for a slice of healthcare that’s long been due for an overhaul. Stern’s got a track...

Continue Reading
Yiddish Prescription Labels Extend Language Access in NY

Updated Category News Views 48

Here's something that might fly under the radar unless you're really in tune with how language impacts healthcare—RxTran's move to include Yiddish on prescription labels might not be rocking financial markets, but it's got a punchy little implication for those of us watching where healthcare intersects with real-world needs. A Push Toward Accessibility Healthcare...

Continue Reading
AppLovin Faces Fraud Lawsuit, Investors Alerted

Updated Category News Views 57

AppLovin's Lawsuit: A Wake-Up Call for Investors The market never forgets, even if some investors might wish reality wasn’t so harsh. On the chopping block this time is AppLovin Corporation (NASDAQ: APP). Seems like their fairy tale with AI turned into a courtroom drama, one that’s throwing a real curveball on those rosy earnings expectations. What's the Case All...

Continue Reading
FFR Schedules Q3 2026 Earnings Call for November 12

Updated Category News Views 104

FFR: On The Edge of Q3 2026 Results Ah, another quarter chock-full of intrigue over at FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR). With their third quarter financial results dropping on November 12, anxious investors are waiting to see some solid numbers amid the clouds of optimistic chatters. Nothing gets the heart racing for us seasoned stock folks like an upcoming...

Continue Reading
Unveiling Federal Credit Lab: A Platform Revolution

Updated Category News Views 22

Navigating the Maze of Federal Lending Well, folks, in the tangled web of federal economics, there's a new player aiming to bring some much-needed clarity. Lafayette Square Institute and the Center for USA Lending have rolled out the Federal Credit Lab. Think of it as a treasure trove of data and insights on federal credit, set to become a trusty compass for policymakers,...

Continue Reading
Slim Chickens Redefines TV Dinners with Smart TV Orders

Updated Category News Views 147

Slim Chickens Takes Over Your Living Room Folks, it looks like the couch just became a whole lot more than a place to binge-watch shows. Slim Chickens is shaking things up by letting you order your favorite wings and tenders right from the Samsung Smart TV home screen in Northwest Arkansas. This hell of a move takes fast-casual dining to a whole new level, mixing the...

Continue Reading

Top 5 Most Recently Viewed Articles

Canton Fair's Southeast Asia Roadshow Strengthens Trade Ties

Updated Category News Views 134

Enhancing Trade Relations at the 137th Canton Fair The 137th Canton Fair continues to solidify its position as China's premier international trade platform. Recently, it hosted a successful Southeast Asia roadshow, conducting impactful trade promotion events aimed at fostering international exchanges throughout the region. Successful Roadshow Across Southeast Asia In...

Continue Reading
Sisecam Expands Leadership in Global Soda Ash Market

Updated Category News Views 466

Sisecam's Strategic Acquisition in the Soda Ash Sector Sisecam recently made a major move in the soda ash industry by acquiring all shares of its partner Ciner Group in the U.S. This acquisition positions Sisecam, a renowned global player in the glass and chemicals sectors, as a potential leader in the soda ash market. Ownership Expansion and Operational Impact This...

Continue Reading
First Trust Advisors Declares Monthly Distribution for ETF

Updated Category News Views 176

First Trust Advisors L.P. Announces Monthly Distribution First Trust Advisors L.P. ("FTA") has officially declared the latest monthly distribution for the First Trust Enhanced Short Maturity ETF, which is part of First Trust Exchange-Traded Fund IV. This important announcement showcases FTA's commitment to providing value to its investors, emphasizing both transparency...

Continue Reading
CloudCasa Enhances Data Security with New Virtualization Support

Updated Category News Views 123

CloudCasa Expands Data Protection Capabilities In the ever-evolving landscape of cloud technology, CloudCasa by Catalogic is making significant strides to enhance data protection solutions. Their recent introduction of support for KubeVirt, SUSE Harvester, and Red Hat OpenShift Virtualization marks a pivotal development for organizations leveraging Kubernetes. This...

Continue Reading
FISPAN Secures $30 Million to Transform Banking for Businesses

Updated Category News Views 377

FISPAN Successfully Raises $30 Million During Series B Funding FISPAN, the market leader in embedded banking solutions, has announced a successful funding round, securing $30 million in Series B financing led by Canapi Ventures. This significant investment aims to propel FISPAN's growth trajectory, further integrating banking services directly into the enterprise resource...

Continue Reading